This independent lab test confirms Retatrutide 40mg from Penguin Peptides at 99.888% purity with an actual measured content of 42.82 mg. The analysis was conducted by Janoshik Labs on January 21, 2026.
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors, researched for its role in metabolic regulation, body composition, and energy expenditure. A purity level of 99.888% reflects high-grade synthesis with negligible impurities.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.